Read more here:
http://stocks.investopedia.
Thursday, June 28, 2012
Investopedia: Arena Pharmaceuticals - One Huge Step Forward, But Many More Remain
Patient (or long-suffering, depending upon your point of view) Arena Pharmaceuticals (Nasdaq:ARNA)
shareholders got some major validation on June 27, 2012, when the
company announced that the FDA had formally approved the company's
weight-loss drug, Belviq (aka lorcaserin). With a commercial launch with
marketing partner Eisai expected around the end of the
year, investor attention now shifts to the questions of whether Belviq
will prove popular with doctors and patients, whether it will get
adequate reimbursement, and what the total market potential will
ultimately be.
Read more here:
http://stocks.investopedia.
Read more here:
http://stocks.investopedia.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment